When Should an Experimental Drug Be Made Widely Available to Persons Suffering from a Catastrophic Condition?

TitleWhen Should an Experimental Drug Be Made Widely Available to Persons Suffering from a Catastrophic Condition?
Publication TypeWeb Article
Year of Publication1990
AuthorsLevy, E
Secondary AuthorsDavis, M
Series TitlePerspectives on the Professions
Volume9
Issue2
PublisherCenter for the Study of Ethics in the Professions, Illinois Institute of Technology
Place PublishedChicago, IL
Publication Languageeng
KeywordsBIOETHICS , Informed Consent , MEDICINE
AbstractDiscusses the ethical implications of letting patients suffering from catastrophic conditions such as AIDS or cancer access to experimental drugs. In some cases, the author argues, access to these drugs can be denied in instances where the desires of an individual to gain access to the drug can be overridden by a legitimately constituted authority when failure to do so is likely to undermine the well-being of society as a whole or to a large number of fellow citizens. One example of this is if early access to the drug makes int difficulty to recruit patients to participate in clinical trials.
URLhttp://ethics.iit.edu/perspective/v9n2%20perspective.pdf
Full Text

Discipline: 

Subject: 

Publication: